Core Viewpoint - Kimberly-Clark Corporation is acquiring Kenvue in a cash and stock transaction valued at approximately $48.7 billion, representing a multiple of 14.3 times Kenvue's last twelve months adjusted EBITDA, or 8.8 times including expected operational synergies of $2.1 billion [2][14]. Group 1: Transaction Details - Kenvue shareholders will receive $3.50 in cash and 0.14625 shares of Kimberly-Clark for each Kenvue share, totaling $21.01 per share based on Kimberly-Clark's closing price as of October 31, 2025 [16]. - The transaction is expected to close in the second half of 2026, subject to shareholder and regulatory approvals [16]. - Kimberly-Clark has secured committed financing from JPMorgan Chase and plans to fund the cash portion of the transaction through its balance sheet and proceeds from the sale of its 51% stake in its International Family Care and Professional (IFP) business [16]. Group 2: Strategic Benefits - The merger will create a complementary product portfolio with iconic brands that serve nearly half of the global population at various life stages, enhancing the combined company's exposure to key categories expected to benefit from long-term growth trends [4][8]. - The combined entity will leverage a strong talent pool and a robust business engine driven by strategic partnerships, category-defining growth, leading science and innovation, differentiated digital models, and excellent operational culture [4][10]. Group 3: Financial Outlook - The combined company is projected to generate approximately $32 billion in annual net revenue and about $7 billion in adjusted EBITDA by 2025, indicating strong growth potential [13]. - Kimberly-Clark and Kenvue have identified approximately $1.9 billion in cost synergies and $500 million in revenue synergies, with a portion offset by $300 million in reinvestment [13]. - The transaction is expected to create immediate value for Kenvue shareholders, with a compelling financial outlook for all stakeholders involved [14].